Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions

Diabetes Research and Clinical Practice

Volumn 77, Issue 2, 2007, Pages 251-257

  Zabetian, Azadeh ^a   Hadaegh, Farzad ^a   Azizi, Fereidoun ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Agreement; Definitions; Kappa; Metabolic syndrome

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; RISK ASSESSMENT; SEX DIFFERENCE; WORLD HEALTH ORGANIZATION;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IRAN; LIFE STYLE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS; SOCIETIES, MEDICAL; TRIGLYCERIDES; WORLD HEALTH ORGANIZATION;

EID: 34247615019     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.12.001     Document Type: Article

References (33)

1. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
2. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
3. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Med. 15 (1998) 539-553
4. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
5. International Diabetes Federation, International Diabetes Federation Press Conference: The IDF consensus worldwide definition of the metabolic syndrome [article online], 2005. Available from http://www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf, accessed 14 April, 2005.
6. Balkau B., and Charles M.A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabetes Med. 16 (1999) 442-443
7. Ford E.S., and Giles W.H. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 26 (2003) 575-581
8. Ford E.S. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 28 (2005) 2745-2749
9. Athyros V.G., Ganotakis E.S., Elisaf M., and Mikhailidis D.P. The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Curr. Med. Res. Opin. 21 (2005) 1157-1159
10. Azizi F., Salehi P., Etemadi A., and Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res. Clin. Pract. 61 (2003) 29-37
11. Lorenzo C., Serrano-Rios M., Martinez-Larrad M.T., Gabriel R., Williams K., Gomez-Gerique J.A., et al. Central adiposity determines prevalence differences of the metabolic syndrome. Obes. Res. 11 (2003) 1480-1487
12. Raymond S.U., Leeder S., and Greenberg H.M. Obesity and cardiovascular disease in developing countries: a growing problem and an economic threat. Curr. Opin. Clin. Nutr. Metab. Care 9 (2006) 111-116
13. Prentice A.M. The emerging epidemic of obesity in developing countries. Int. J. Epidemiol. 35 (2006) 93-99
14. Azizi F., Azadbakht L., and Mirmiran P. Trends in overweight, obesity and central fat accumulation among Tehranian adults between 1998-1999 and 2001-2002: Tehran lipid and glucose study. Ann. Nutr. Metab. 49 (2005) 3-8
15. Azadbakht L., Mirmiran P., Shiva N., and Azizi F. General obesity and central adiposity in a representative sample of Tehranian adults: prevalence and determinants. Int. J. Vitam. Nutr. Res. 75 (2005) 297-304
16. Rashidi A., Mohammadpour-Ahranjani B., Vafa M.R., and Karandish M. Prevalence of obesity in Iran. Obes. Rev. 6 (2005) 191-192
17. Azizi F., Rahmani M., Emami H., Mirmiran P., Hajipour R., Madjid M., et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz. Praventivmed. 47 (2002) 408-426
18. Laaksonen D.E., Lakka H.M., Niskanen L.K., Kaplan G.A., Salonen J.T., and Lakka T.A. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am. J. Epidemiol. 156 (20021070-) 7
19. O. Ahmad, C. Boschi-Pinto, A. Lopez, C.J.L. Murray, R. Lozano, M. Inoue, Age Standardization of Rates: a New WHO Standard (GPE Discussion Paper Series No. 31), World Health Organization, Geneva, 2000.
20. Altman D.G. Some Practical Statistics for Medical Research. 1st ed. (1991), Champan and Hall p. 404
21. Aguilar-Salinas C.A., Rojas R., Gomez-Perez F.J., Valles V., Rios-Torres J.M., Franco A., et al. Analysis of the agreement between the World Health Organization criteria and the National Cholesterol Education Program-III definition of the metabolic syndrome: results from a population-based survey. Diabetes Care 26 (2003) 1635
22. Tillin T., Forouhi N., Johnston D.G., McKeigue P.M., Chaturvedi N., and Godsland I.F. Metabolic syndrome and coronary heart disease in South Asians, African-Caribbean and white Europeans: a UK population-based cross-sectional study. Diabetologia 48 (2005) 649-656
23. Jorgensen M.E., Bjerregaard P., Gyntelberg F., and Borch-Johnsen K. Greenland Population Study. Prevalence of the metabolic syndrome among the Inuit in Greenland. A comparison between two proposed definitions. Diabetes Med. 21 (2004) 1237-1242
24. Martinez Candela J., Franch Nadal J., Romero Ortiz J., Canovas Dominguez C., Gallardo Martin A., and Paez Perez M. Prevalence of metabolic syndrome in the adult population of yecla (murcia). Degree of agreement between three definitions of it. Aten Primaria 38 (2006) 72-79
25. Rathmann W., Haastert B., Icks A., Giani G., Holle R., Koenig W., et al. Prevalence of the metabolic syndrome in the elderly population according to IDF, WHO, and NCEP definitions and associations with C-reactive protein: the KORA Survey 2000. Diabetes Care 29 (2006) 461
26. Deepa M., Farooq S., Datta M., Deepa R., and Mohan V. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab. Res. Rev. (2006) [Epub ahead of print]
27. Ko G.T., Cockram C.S., Chow C.C., Yeung V.T., Chan W.B., So W.Y., et al. Metabolic syndrome by the international diabetes federation definition in Hong Kong Chinese. Diabetes Res. Clin. Pract. 73 (2006) 58-64
28. Park H.S., Lee S.Y., Kim S.M., Han J.H., and Kim D.J. Prevalence of the metabolic syndrome among Korean adults according to the criteria of the International Diabetes Federation. Diabetes Care 29 (2006) 933-934
29. Azizi F., Raiszadeh F., Salehi P., Rahmani M., Emami H., Ghanbarian A., et al. Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study. Nutr. Metab. Cardiovasc. Dis. 12 (2002) 80-89
30. Meigs J.B., Wilson P.W., Nathan D.M., D'Agostino Sr. R.B., Williams K., and Haffner S.M. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 52 (2003) 2160-2167
31. Bahrami H., Sadatsafavi M., Pourshams A., Kamangar F., Nouraei M., Semnani S., et al. Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American women. BMC Public Health 6 (2006) 158
32. Guerrero-Romero F., and Rodriguez-Moran M. Concordance between the 2005 International Diabetes Federation definition for diagnosing metabolic syndrome with the National Cholesterol Education Program Adult Treatment Panel III and the World Health Organization definitions. Diabetes Care 28 (2005) 2588-2589
33. Hadaegh F., Zabetian A., Harati H., and Azizi F. Waist/height ratio as a better predictor of type 2 diabetes compared to body mass index in Tehranian adult men-a 3.6-year prospective study. Exp. Clin. Endocrinol. Diabetes 114 (2006) 310-315